Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent.

Saved in:
Bibliographic Details
Title: Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent.
Authors: Arnon J; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel. arnony@hadassah.org.il.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. arnony@hadassah.org.il., Zick A; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Maoz M; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel., Salaymeh N; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel., Gugenheim A; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel., Marouani M; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Mor E; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Hamburger T; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel., Saadi N; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Elia A; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Pathology, Hadassah University Medical Center, Jerusalem, Israel., Ganz G; Department of Genetics, Hadassah University Medical Center, Jerusalem, Israel., Fahham D; Department of Genetics, Hadassah University Medical Center, Jerusalem, Israel., Meirovitz A; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Kadouri L; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Meiner V; Department of Genetics, Hadassah University Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Yablonski-Peretz T; Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Shkedi-Rafid S; Department of Genetics, Hadassah University Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Source: Familial cancer [Fam Cancer] 2024 Nov; Vol. 23 (4), pp. 531-542. Date of Electronic Publication: 2024 May 14.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7292
DOI:10.1007/s10689-024-00391-2